Martín-Arana et al. present a highly sensitive tumor-agnostic assay to detect minimal residual disease based on whole-exome sequencing of longitudinal circulating tumor DNA samples from persons with relapsed colon cancer and on genomic data from metastases.
- Jorge Martín-Arana
- Francisco Gimeno-Valiente
- Noelia Tarazona